http://jcps.bjmu.edu.cn

Journal of Chinese Pharmaceutical Sciences ›› 2014, Vol. 23 ›› Issue (7): 446-453.DOI: 10.5246/jcps.2014.07.059

• Original articles • Previous Articles     Next Articles

Scalable synthesis of salidroside

Qingzhao Liang, Hui Li, Wenxuan Zhang, Xiangbao Meng, Zhongjun Li*   

  1. State Key Laboratory of Natural and Biomimetic Drugs; Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University Health Sciences Center, Beijing 100191, China
  • Received:2014-04-01 Revised:2014-04-13 Online:2014-07-18 Published:2014-04-18
  • Contact: Tel.: 86-10-82801714
  • Supported by:
    National Basic Research Program of China (973 Program, Grant No. 2012CB822100), the National Key Technology R&D Program “New Drug Innovation” of China (Grant No. 2012ZX09502001-001) and the National Natural Science Foundation of China (Grant No. 21232002, 21072016 and 21072017).

Abstract:

By analyzing the key steps that restricted the industrial synthesis of salidroside, selective protection of tyrosol with different acylation reagents was adopted. The strategy facilitated the crystallization of intermediates, which allowed the scalable synthesis of salidroside. It included a reaction of penta-O-acetyl-β-D-glucose with acyl protected tyrosol in the presence of Lewis acid catalyst (ZnCl2), followed by deacylation under basic condition (NaOMe/MeOH) to give the salidroside. The total yield of this three-step reaction was 47%. Final product and intermediates were purified by recrystallization, which significantly reduced the cost and made the large scale synthesis feasible.

Key words: Salidroside, Acylation of tyrosol, Crystallization, Scale up feasibility, Synthesis

CLC Number: 

Supporting: